OVERVIEW

The Transplant Diagnostics Market is expected to reach USD 5.8 billion by 2026, growing at a CAGR of 7.2% during the forecast period. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures like stopping of transplants, elective and non elective, surgeries that are carried out in hospitals. However, with the post pandemic era it is expected to revive the market and increase the market growth.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Transplant Diagnostics Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Transplant Diagnostics Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Transplant Diagnostics Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Transplant Diagnostics Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Transplant Diagnostics Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Transplant Diagnostics Market ? By Technology (Market Size ? & million/billion)
  • 8.1 Molecular Assay Technologies
  • 8.2 Non-molecular Assay Technologies

• 9 Global Transplant Diagnostics Market - By Product & Service
  • 9.1 Reagents & Consumables
  • 9.2 Instruments
  • 9.3 Software & Services

• 10 Global Transplant Diagnostics Market - By Transplant Type
  • 10.1 Solid Organ Transplantation
  • 10.2 Stem Cell Transplantation
  • 10.3 Soft Tissue Transplantation
  • 10.4 Bone marrow Transplantation

• 11 Global Transplant Diagnostics Market - By Application
  • 11.1 Diagnostic Applications
  • 11.2 Research Applications

• 12 Global Transplant Diagnostics Market - By End-User
  • 12.1 Independent Reference Laboratories
  • 12.2 Hospitals & Transplant Centers
  • 12.3 Research Laboratories & Academic Institutes

• 13 Global Transplant Diagnostics Market ? By Geography (Market Size ? & million/billion)
  • 13.1 Introduction
  • 13.2 North America
    • 13.2.1 US
    • 13.2.2 Canada
    • 13.2.3 Mexico
  • 13.3 Europe
    • 13.3.1 U.K
    • 13.3.2 Germany
    • 13.3.3 Italy
    • 13.3.4 France
    • 13.3.5 Spain
    • 13.3.6 Rest of Europe
  • 13.4 Asia-Pacific
    • 13.4.1 China
    • 13.4.2 Japan
    • 13.4.3 India
    • 13.4.4 South Korea
    • 13.4.5 Rest of APAC
  • 13.5 Rest of the World
    • 13.5.1 South America
    • 13.5.2 Middle East
    • 13.5.3 Africa

• 14 Global Transplant Diagnostics Market ? Entropy
  • 14.1 New product launches
  • 14.2 M&A's, collaborations, JVs and partnerships

• 15 Global Transplant Diagnostics Market Company Profile (Key Players)
  • 15.1 Market Share, Company Revenue, Products, M&A, Developments
  • 15.2 Becton, Dickinson and Company
  • 15.3 Biofortuna
  • 15.4 Biom?rieux SA
  • 15.5 Bio-Rad Laboratories
  • 15.6 Caredx
  • 15.7 Illumina, Inc.
  • 15.8 Gendx
  • 15.9 Immucor, Inc.
  • 15.10 F. Hoffman-La Roche Limited
  • 15.11 Hologic, Inc.
  • 15.12 Company 11 & more

• 16 Global Transplant Diagnostics Market - Appendix
  • 16.1 Sources
  • 16.2 Abbreviations